Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1978 ARTÍCULOS , VIENDO DEL 16 AL 30

Sigma-2 Receptor as a Potential Drug Target

Chen AF, Ma WH, Xie XY, Huang YS.

Curr Med Chem. 2021;28(21):4172-4189. doi: 10.2174/0929867327666200902172615.

Decoding the Inter-Relationship between Sleep Disorders and Alzheimer's Disease Pathogenesis

Mueed Z, Rai PK, Kamal MA, Poddar NK.

CNS Neurol Disord Drug Targets. 2021;20(8):723-735. doi: 10.2174/1871527319666200903161249.

Metformin: A Growing Journey from Glycemic Control to the Treatment of Alzheimer's Disease and Depression

El Massry M, Alaeddine LM, Ali L, Saad C, Eid AA.

Curr Med Chem. 2021;28(12):2328-2345. doi: 10.2174/0929867327666200908114902.

From Hybrids to New Scaffolds: The Latest Medicinal Chemistry Goals in Multi-target Directed Ligands for Alzheimer's Disease

Alarcón-Espósito J, Mallea M, Rodríguez-Lavado J.

Curr Neuropharmacol. 2021;19(6):832-867. doi: 10.2174/1570159X18666200914155951.

The Pathogenesis Mechanism, Structure Properties, Potential Drugs and Therapeutic Nanoparticles against the Small Oligomers of Amyloid-β

Wang K, Na L, Duan M.

Curr Top Med Chem. 2021;21(2):151-167. doi: 10.2174/1568026620666200916123000.

Diabetic Theory in Anti-Alzheimer's Drug Research and Development. Part 2: Therapeutic Potential of cAMP-Specific Phosphodiesterase Inhibitors

Jankowska A, Pawłowski M, Chłoń-Rzepa G.

Curr Med Chem. 2021;28(18):3535-3553. doi: 10.2174/0929867327666200917125857.

Carbon Nano Tubes: Novel Drug Delivery System in Amelioration of Alzheimer's Disease

Mishra J, Kumar B, Pandey M, Pottoo FH, Fayaz F, Khan FA, Sahoo PK.

Comb Chem High Throughput Screen. 2021;24(10):1528-1543. doi: 10.2174/1386207323999200918112538.

Inflammation Drives Alzheimer's Disease: Emphasis on 5-lipoxygenase Pathways

Siddiqui A, Akhtar S, Shah Z, Othman I, Kumari Y.

Curr Neuropharmacol. 2021;19(6):885-895. doi: 10.2174/1570159X18666200924122732.

Phytochemicals for Drug Discovery in Alzheimer's Disease: In Silico Advances

Sharma S, Bhatia V.

Curr Pharm Des. 2021;27(25):2848-2860. doi: 10.2174/1381612826666200928161721.

Multi-Target Directed Compounds with Antioxidant and/or Anti- Inflammatory Properties as Potent Agents for Alzheimer's Disease

Papagiouvannis G, Theodosis-Nobelos P, Kourounakis PN, Rekka EA.

Med Chem. 2021;17(10):1086-1103. doi: 10.2174/1573406416666201013161303.

Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis

Kunkle BW, Schmidt M, Klein HU, Naj AC, Hamilton-Nelson KL, Larson EB, Evans DA, De Jager PL, Crane PK, Buxbaum JD, Ertekin-Taner N, Barnes LL, Fallin MD, Manly JJ, Go RCP, Obisesan TO, Kamboh MI, Bennett DA, Hall KS, Goate AM, Foroud TM, Martin ER, Wang LS, Byrd GS, Farrer LA, Haines JL, Schellenberg GD, Mayeux R, Pericak-Vance MA, Reitz C; Writing Group for the Alzheimer’s Disease Genetics Consortium (ADGC); Graff-Radford NR, Martinez I, Ayodele T, Logue MW, Cantwell LB, Jean-Francois M, Kuzma AB, Adams LD, Vance JM, Cuccaro ML, Chung J, Mez J, Lunetta KL, Jun GR, Lopez OL, Hendrie HC, Reiman EM, Kowall NW, Leverenz JB, Small SA, Levey AI, Golde TE, Saykin AJ, Starks TD, Albert MS, Hyman BT, Petersen RC, Sano M, Wisniewski T, Vassar R, Kaye JA, Henderson VW, DeCarli C, LaFerla FM, Brewer JB, Miller BL, Swerdlow RH, Van Eldik LJ, Paulson HL, Trojanowski JQ, Chui HC, Rosenberg RN, Craft S, Grabowski TJ, Asthana S, Morris JC, Strittmatter SM, Kukull WA.

JAMA Neurol. 2021 Jan 1;78(1):102-113. doi: 10.1001/jamaneurol.2020.3536.

Chalcones Acting as Inhibitors of Cholinesterases, β-Secretase and β- Amyloid Aggregation and other Targets for Alzheimer's Disease: A Critical Review

Antoniolli G, Almeida WP, Frias CC, de Oliveira TB.

Curr Med Chem. 2021;28(21):4259-4282. doi: 10.2174/0929867327666201020151804.

Enhancing Therapeutic Efficacy of Donepezil by Combined Therapy: A Comprehensive Review

Rong X, Jiang L, Qu M, Hassan SSU, Liu Z.

Curr Pharm Des. 2021;27(3):332-344. doi: 10.2174/1381612826666201023144836.

Putative Involvement of Endocrine Disruptors in the Alzheimer's Disease Via the Insulin-Regulated Aminopeptidase/GLUT4 Pathway

Ramírez-Expósito MJ, Martínez-Martos JM, Cantón-Habas V, Del Pilar Carrera-González M.

Curr Neuropharmacol. 2021;19(7):939-956. doi: 10.2174/1570159X18666201111103024.

Glia-Driven Neuroinflammation and Systemic Inflammation in Alzheimer's Disease

Hashioka S, Wu Z, Klegeris A.

Curr Neuropharmacol. 2021;19(7):908-924. doi: 10.2174/1570159X18666201111104509.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias